New blood treatment could block zika in transfusions

NCT ID NCT03037164

Ongoing Disease control Sponsor: Cerus Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special treatment for red blood cells that aims to kill the Zika virus, making transfusions safer. About 692 people who need blood transfusions will receive either treated or standard blood. The goal is to see if the treated blood works just as well and is safe, while reducing the risk of spreading Zika.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia aplastic anemia myelodysplastic syndrome sickle cell disease thalassemia Zika virus infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA

Contacts and locations

Locations

Baylor St. Luke's Medical Center

Houston, Texas, 77303, United States
C4TKs (Cure 4 The Kids)

Las Vegas, Nevada, 89135, United States
CHOA (Children's Healthcare of Atlanta)

Atlanta, Georgia, 30316, United States
Ege University Hospital

Izmir, 35100, Turkey (Türkiye)
Grady Health System

Atlanta, Georgia, 30303, United States
HIMA San Pablo Hospital

Caguas, 00725, Puerto Rico
Mayo Clinic Jacksonville

Jacksonville, Florida, 32224, United States
Menonita General Hospital

Aibonito, 00705, Puerto Rico
Phoenix Children's Hospital (PCH)

Phoenix, Arizona, 85016, United States
San Juan Bautista School of Medicine Clinical Research Unit

Caguas, 00725, Puerto Rico
St Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States
UT Southwestern Medical Center

Dallas, Texas, 75390, United States
University of Maryland School of Medicine

Baltimore, Maryland, 21201, United States
Versiti

Wauwatosa, Wisconsin, 53226, United States
Virginia Commonwealth University

Richmond, Virginia, 23298, United States
Yale University

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.